Inactive Instrument

Other languages Lansen Pharmaceutical Holdings Limited

Equities

503 KYG5380M1033

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Lansen Pharmaceutical to Delist from HKEX on Dec. 19	Dec. 18
Cayman Islands Court Approves Takeover, Privatization of Lansen Pharma	Dec. 15
Cathay International Holdings Limited completed the acquisition of additional 31.78% stake in Lansen Pharmaceutical Holdings Limited.	Dec. 14
Cathay International Pharma to Privatize Lansen Pharmaceutical in HK$239 Million Deal	23-09-18
Lansen Pharmaceutical's H1 Profit Slides 17%	23-08-24
Lansen Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24
Lansen Pharmaceutical Holdings Limited commences an Equity Buyback Plan for 42,243,243 shares, representing 10% of its issued share capital, under the authorization approved on June 21, 2023.	23-06-23
Lansen Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24
Lansen Pharmaceutical Holdings Limited Declares Interim Dividend	23-03-24
Lansen Pharmaceutical Expects 2022 Profit Soaring 798%; Shares Surge 22%	23-01-16
Lansen Pharmaceutical Holdings Limited Provides Earnings Guidance for the Twelve Months Ended 31 December 2022	23-01-15
Lansen Pharmaceutical Holdings Limited Appoints Zhu Xun as Independent Non-Executive Director and Member of the Remuneration Committee	22-09-23
Lansen Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31
Lansen Pharmaceutical Holdings Limited commences an Equity Buyback Plan for 42,683,400 shares, representing 10% of its issued share capital, under the authorization approved on June 23, 2022.	22-06-24
Lansen Pharmaceutical Holdings Limited Approves to Elect Chan Ching Har, Eliza as an Independent Non-Executive Director	22-06-23
Lansen Pharma Sees Better Financial Performance in H1	22-06-15
Lansen Pharmaceutical Holdings Limited Announces Resignation of Stephen Burnau Hunt as Non-Executive Director and Member of the Remuneration Committee	22-04-11
Hong Kong Stocks Edge Up after Wall Street Gains; Lansen Pharma Jumps 13%	22-04-08
Lansen Pharma to Raise Nearly $8 Million From Private Placement; Shares Jump 12%	22-04-08
Lansen Pharmaceutical Holdings to Seek Acquisitions	22-04-07

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Lansen Pharmaceutical Holdings Limited

Equities

503

KYG5380M1033

Other languages

Filters